Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathers

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
ACS Medicinal Chemistry Letters|August 20, 2025
Discovery of Osivelotor (GBT021601): A Potent, Next-Generation Sickle Hemoglobin Polymerization InhibitorZhe Li, Carsten Alt, Kobina Dufu, et al.
Air Medical Journal|March 15, 2024
Association of Geographic Distance and Hospital Characteristics With Use of Interhospital Transfer by Air: A Multicenter Retrospective StudyBennett H Lane, David J Rea, Adam L Gottula, et al.
Scientific Reports|November 2, 2022
In silico, in vitro and in vivo characterization of host-associated Latilactobacillus curvatus strains for potential probiotic applications in farmed Atlantic salmon (Salmo salar)Hannah S Cathers, Shrinivasrao P Mane, Nilesh R Tawari, et al.
Annals of Internal Medicine|September 6, 2016
Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care PatientsJennifer McNeely, Li-Tzy Wu, Geetha Subramaniam, et al.
Journal of Racial and Ethnic Health Disparities|February 23, 2021
Increasing Prenatal Care Compliance in At-Risk Black Women: Findings from a RCT of Patient Navigation and Behavioral IncentivesDace S Svikis, Sydney S Kelpin, Lori Keyser-Marcus, et al.
Journal of General Internal Medicine|May 28, 2017
Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary CareJan Gryczynski, Jennifer McNeely, Li-Tzy Wu, et al.
Journal of Medicinal Chemistry|February 16, 2021
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid LeukemiaJoshua D Hansen, Matthew Correa, Matt Alexander, et al.
Elife|September 21, 2018
UBE2G1 governs the destruction of cereblon neomorphic substratesGang Lu, Stephanie Weng, Mary Matyskiela, et al.
British Journal of Haematology|March 24, 2023
GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine modelKobina Dufu, Carsten Alt, Steven Strutt, et al.
British Journal of Haematology|February 26, 2016
Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myelomaEmily Rychak, Derek Mendy, Tao Shi, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
ACS Medicinal Chemistry Letters|August 20, 2025
Discovery of Osivelotor (GBT021601): A Potent, Next-Generation Sickle Hemoglobin Polymerization InhibitorZhe Li, Carsten Alt, Kobina Dufu, et al.
Air Medical Journal|March 15, 2024
Association of Geographic Distance and Hospital Characteristics With Use of Interhospital Transfer by Air: A Multicenter Retrospective StudyBennett H Lane, David J Rea, Adam L Gottula, et al.
Scientific Reports|November 2, 2022
In silico, in vitro and in vivo characterization of host-associated Latilactobacillus curvatus strains for potential probiotic applications in farmed Atlantic salmon (Salmo salar)Hannah S Cathers, Shrinivasrao P Mane, Nilesh R Tawari, et al.
Annals of Internal Medicine|September 6, 2016
Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care PatientsJennifer McNeely, Li-Tzy Wu, Geetha Subramaniam, et al.
Journal of Racial and Ethnic Health Disparities|February 23, 2021
Increasing Prenatal Care Compliance in At-Risk Black Women: Findings from a RCT of Patient Navigation and Behavioral IncentivesDace S Svikis, Sydney S Kelpin, Lori Keyser-Marcus, et al.
Journal of General Internal Medicine|May 28, 2017
Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary CareJan Gryczynski, Jennifer McNeely, Li-Tzy Wu, et al.
Journal of Medicinal Chemistry|February 16, 2021
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid LeukemiaJoshua D Hansen, Matthew Correa, Matt Alexander, et al.
Elife|September 21, 2018
UBE2G1 governs the destruction of cereblon neomorphic substratesGang Lu, Stephanie Weng, Mary Matyskiela, et al.
British Journal of Haematology|March 24, 2023
GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine modelKobina Dufu, Carsten Alt, Steven Strutt, et al.
British Journal of Haematology|February 26, 2016
Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myelomaEmily Rychak, Derek Mendy, Tao Shi, et al.
Pageof 13